Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus

Circulation Journal

Volumn 68, Issue 11, 2004, Pages 993-998

  Yanagisawa, Hidefumi ^a   Chikamori, Taishiro ^a   Tanaka, Nobuhiro ^a   Usui, Yasuhiro ^a   Takazawa, Kenji ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Coronary circulation; Diabetes mellitus; Fractional flow reserve; Thallium myocardial imaging

Indexed keywords

HEMOGLOBIN A1C; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA PRESSURE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; CORONARY RISK; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; STATISTICAL ANALYSIS;

AGED; AREA UNDER CURVE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 9144255517     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.993     Document Type: Article

References (32)

1. De Bruyne B, Pijls NH, Paulus WJ, Vantrimpont PJ, Sys SU, Heyndrickx GR. Transstenotic coronary pressure gradient measurement in humans: In vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire. J Am Coll Cardiol 1993; 22: 119-126.
2. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-1367.
3. Serruys PW, di Mario C, Piek J, Schroeder E, Vrints C, Probst P, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation 1997; 96: 3369-3377.
4. 201T1 imaging and coronary angiography. Circulation 1997; 96: 484-490.
5. Yanagisawa H, Chikamori T, Tanaka N, Hatano T, Morishima T, Hida S, et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J 2002; 66: 1105-1109.
6. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017-1025.
7. Pitkanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998; 47: 248-254.
8. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-640.
9. Di Cari MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003; 41: 1387-1393.
10. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, et al. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 1997; 30: 935-941.
11. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
12. The Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus. Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 1999; 42: 385-404 (in Japanese).
13. Yamagishi H, Akioka K, Takagi M, Tanaka A, Takeuchi K, Yoshikawa J, et al. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Heart 1998; 80: 28-34.
14. Hida S, Chikamori T, Hirayama T, Usui Y, Yanagisawa H, Morishima T, et al. Beneficial effect of coronary artery bypass grafting as assessed by quantitative gated single-photon emission computed tomography. Circ J 2003; 67: 499-504.
15. Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutzu H, Imachi T, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 1995; 26: 1196-1201.
16. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
17. Berman DS, Germano G. Myocardial perfusion single photon approaches. In: Pohost GM, O'Rourke RA, Berman DS, Shah PM, editors. Imaging in cardiovascular disease. Philadelphia: Lippincott Williams & Wilkins; 2000; 159-194.
18. Hida S, Chikamori T, Usui Y, Yanagisawa H, Morishima T, Yamashina A. Effect of percutaneous coronary angioplasty on myocardial perfusion, function, and wall thickness as assessed by quantitative gated single-photon emission computed tomography. Am J Cardiol 2003; 91: 591-594.
19. AHA Committee. A reporting system on patients evaluated for coronary artery disease. Circulation 1975; 51: 5-34.
20. Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193.
21. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995; 92: 39-46.
22. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708.
23. Usui Y, Chikamori T, Yanagisawa H, Morishima T, Hida S, Tanaka N, et al. Reliability of pressure-derived myocardial fractional flow reserve in assessing coronary artery stenosis in patients with previous myocardial infarction. Am J Cardiol 2003; 92: 699-702.
24. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001; 104: 157-162.
25. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
26. Takiuchi S, Rakugi H, Masuyama T, Ikegami H, Nishikage T, Shintani M, et al. Hypertension attenuates the efficacy of hypoglycemic therapy for preserving coronary flow reserve in patients with type 2 diabetes. Hypertens Res 2002; 25: 893-900.
27. Wilson RF, White CW. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986; 73: 444-451.
28. Murtagh B, Higano S, Lennon R, Mathew V, Holmes DR Jr, Lerman A. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 2003; 146: 99-105.
29. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R. Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. J Am Coll Cardiol 2003; 41: 1114-1121.
30. Asakura Y, Suzuki M, Nonogi H, Haze K, Sato A, Inada H, et al. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM). J Cardiovasc Risk 1998; 5: 331-334.
31. Mazeika P, Prasad N, Bui S, Seidelin PH. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 2003; 145: 1013-1021.
32. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004; 43: 8-14.